Effect of Thunder fire moxibustion for postoperative fatigue in patients undergoing total knee replacement surgery

注册号:

Registration number:

ITMCTR2023000071

最近更新日期:

Date of Last Refreshed on:

2023-12-25

注册时间:

Date of Registration:

2023-12-25

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

雷火灸对全膝关节置换手术患者术后疲乏的效果评价

Public title:

Effect of Thunder fire moxibustion for postoperative fatigue in patients undergoing total knee replacement surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

雷火灸对全膝关节置换手术患者术后疲乏的临床干预研究

Scientific title:

Clinical intervention study of thunder fire moxibustion on postoperative fatigue in patients undergoing total knee replacement surgery

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

廖若彤

研究负责人:

傅秀珍

Applicant:

Ruotong Liao

Study leader:

Xiuzhen Fu

申请注册联系人电话:

Applicant telephone:

19865488275

研究负责人电话:

Study leader's telephone:

+86 020-8188-7233

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

20192110644@stu.gzucm.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

1962238666@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

广东省广州市越秀区大德路111号

研究负责人通讯地址:

广东省广州市越秀区大德路111号

Applicant address:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

Study leader's address:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广东省中医院

Applicant's institution:

Guangdong Provincial Hospital of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

BF2023-060-01

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

广东省中医院伦理委员会

Name of the ethic committee:

The Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2023/4/14 0:00:00

伦理委员会联系人:

李晓彦

Contact Name of the ethic committee:

Xiaoyan Li

伦理委员会联系地址:

广东省广州市越秀区大德路111号

Contact Address of the ethic committee:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 020 81887233-35943

伦理委员会联系人邮箱:

Contact email of the ethic committee:

llbgs@gzucm.edu.cn

研究实施负责(组长)单位:

广东省中医院

Primary sponsor:

Guangdong Provincial Hospital of Chinese Medicine

研究实施负责(组长)单位地址:

广东省中医院

Primary sponsor's address:

Guangdong Provincial Hospital of Chinese Medicine

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

广东省中医院

具体地址:

广州市越秀区大德路111号

Institution
hospital:

Guangdong Provincial Hospital of Chinese Medicine

Address:

111 Dade Road, Yuexiu District, Guangzhou

经费或物资来源:

广东省中医院中医药科学技术研究专项

Source(s) of funding:

Guangdong Provincial Hospital of Traditional Chinese Medicine Science and Technology Research Project

研究疾病:

术后疲乏

研究疾病代码:

Target disease:

postoperative fatigue

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

观察雷火灸对全膝关节置换术患者术后疲乏的影响;客观评价雷火灸在术后疲乏中的应用效果,为临床合理使用提供科学依据

Objectives of Study:

To observe the effect of Thunder Fire Moxibustion on postoperative fatigue in patients undergoing total knee arthroplasty; and to evaluate the application effect of thunder fire moxibustion in postoperative fatigue, providing scientific basis for rational clinical use.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)年龄在50-85岁之间,性别不限; (2)诊断为骨关节炎,住院择期在全麻下行单侧膝关节置换手术; (3)美国麻醉医师协会(ASA)分级为Ⅲ级或Ⅳ级; (4)自愿参与本研究并签署知情同意书。

Inclusion criteria

(1) Age range from 50 to 85 years old, regardless of gender; (2) Diagnosed as osteoarthritis, hospitalized and scheduled for unilateral knee replacement surgery under general anesthesia; (3) The American Society of Anesthesiologists (ASA) is classified as Level III or IV; (4) Voluntarily participate in this study and sign an informed consent form.

排除标准:

(1)合并严重心律失常、心力衰竭、癫痫、精神疾病等; (2)神阙、关元、气海、足三里、三阴交等穴位处皮肤破损、破溃; (3)存在雷火灸应用禁忌(如发热,周围神经病变感觉异常等); (4)腹部肿瘤等不宜在腹部施灸者; (5)糖尿病病史患者。

Exclusion criteria:

(1) Concomitant severe arrhythmia, heart failure, epilepsy, mental illness, etc; (2) Skin damage and ulceration at acupoints such as Shenque, Guanyuan, Qihai, Zusanli, and Sanyinjiao; (3) There are contraindications for the application of lightning fire moxibustion (such as fever, peripheral neuropathy, sensory abnormalities, etc.); (4) Abdominal tumors and other unsuitable areas for moxibustion in the abdomen; (5) Patients with a history of diabetes. 笔记

研究实施时间:

Study execute time:

From 2023-04-14

To      2024-04-14

征募观察对象时间:

Recruiting time:

From 2023-04-14

To      2024-04-05

干预措施:

Interventions:

组别:

对照组

样本量:

48

Group:

(control group

Sample size:

干预措施:

常规护理

干预措施代码:

Intervention:

usual care

Intervention code:

组别:

干预组

样本量:

48

Group:

intervention group

Sample size:

干预措施:

雷火灸

干预措施代码:

Intervention:

thunder fire moxibustion

Intervention code:

样本总量 Total sample size : 96

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

广东

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

广东省中医院

单位级别:

三级甲等

Institution/hospital:

Guangdong Provincial Hospital of traditional Chinese medicine

Level of the institution:

tertiary A

测量指标:

Outcomes:

指标中文名:

术后疲乏

指标类型:

主要指标

Outcome:

postoperative fatigue

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

baseline

Measure method:

scale

指标中文名:

关节活动度

指标类型:

次要指标

Outcome:

range of motion

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

炎性指标

指标类型:

次要指标

Outcome:

Inflammatory indicators

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 50
Min age years
最大 65
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由SPSS20.0软件随机生成96个随机数字,奇数代表实验组,偶数代表对照组,将96份随机数字卡片装入密封信封内,信封编号与卡片编号一致,并将信封按编号大小顺序进行排列,由专人负责,按照入院先后顺序抽取相应序号的信封进行随机分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

由SPSS20.0软件随机生成96个随机数字,奇数代表实验组,偶数代表对照组,将96份随机数字卡片装入密封信封内,信封编号与卡片编号一致,并将信封按编号大小顺序进行排列,由专人负责,按照入院先后顺序抽取相应序号的信封进行随机分组。 96 random numbers were randomly generated using SPSS20.0 software, with odd numbers representing the experimental group and even numbers representing the control group. 96 random number cards were placed in sealed envelopes with the same envelope number as the card number, and the envelopes were arranged in order of number size. A dedicated person was responsible for randomly grouping envelopes with corresponding numbers according to the order of admission.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan临床试验公共管理平台http://www.medresman.org.cn/uc/index.aspx

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan research manager,http://www.medresman.org.cn/uc/index.aspx

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

临床病例观察表,Excel, SPSS

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF,excel,SPSS

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above